Table 2.
N=21 | ||
---|---|---|
pT | T2 15 (71%) | T3 6 (29%) |
GS | 6 | 4 (19%) |
7 | 10 (48%) | |
8–10 | 4 (19%) | |
Treatment effect | 3 (14%) | |
EPE | No | 15 (71%) |
Yes | 6 (29%) | |
SVI | No | 18 (86%) |
Yes | 3 (14%) | |
Positive margin | No | 17 (81%) |
Yes | 4 (19%) | |
PLND | No | 13 (62%) |
Yes | 8 (38%) | |
Positive LN | No | 7 (88%) |
Yes | 1 (12%) |
GS: Gleason score; EPE: extraprostatic extension SVI: seminal vesicle involvement; PLND: pelvic lymph node dissection; LN: lymph node.